CIK: 0001802528 · Show all filings
Period: Q3 2020 (← Previous) (Next →)
Filing Date: Nov 12, 2020
Total Value ($000): $236,102 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| INSM | INSMED INC | 1,056,797 | $33,965 | 14.4% | $20.81 | +38.1% | COM PAR $.01 | 457669307 |
| ACAD | ACADIA PHARMACEUTICALS INC | 647,833 | $26,723 | 11.3% | $43.17 | +0.0% | COM | 004225108 |
| — | TRILLIUM THERAPEUTICS INC | 1,558,181 | $22,142 | 9.4% | $4.53 | — | COM NEW | 89620X506 |
| FOLD | AMICUS THERAPEUTICS INC | 1,455,395 | $20,550 | 8.7% | $9.80 | +48.7% | COM | 03152W109 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 596,890 | $19,650 | 8.3% | $24.87 | +23.3% | COM | 462260100 |
| — | ZOGENIX INC | 1,056,875 | $18,950 | 8.0% | $36.29 | — | COM NEW | 98978L204 |
| AXSM | AXSOME THERAPEUTICS INC | 220,098 | $15,682 | 6.6% | $80.87 | -3.6% | COM | 05464T104 |
| — | UNUM THERAPEUTICS INC | 6,235,903 | $13,716 | 5.8% | $2.20 | — | COM | 903214104 |
| — | ALLAKOS INC | 164,662 | $13,412 | 5.7% | $81.12 | — | COM | 01671P100 |
| ARGX | ARGENX SE | 49,950 | $13,113 | 5.6% | $160.52 | — | SPONSORED ADR | 04016X101 |
| — | KARYOPHARM THERAPEUTICS INC | 702,351 | $10,254 | 4.3% | $18.82 | — | COM | 48576U106 |
| ENTA | ENANTA PHARMACEUTICALS INC | 162,236 | $7,427 | 3.1% | $61.59 | -21.3% | COM | 29251M106 |
| — | AMARIN CORP PLC | 1,508,237 | $6,350 | 2.7% | $14.78 | — | SPONS ADR NEW | 023111206 |
| — | MIRATI THERAPEUTICS INC | 35,000 | $5,812 | 2.5% | $166.06 | — | COM | 60468T105 |
| — | NEOLEUKIN THERAPEUTICS INC | 372,748 | $4,473 | 1.9% | $12.32 | — | COM | 64049K104 |
| — | KINIKSA PHARMACEUTICALS LTD | 212,746 | $3,259 | 1.4% | $12.03 | — | COM CL A | G5269C101 |
| — | VERONA PHARMA PLC | 100,000 | $624 | 0.3% | $6.24 | — | SPONSORED ADS | 925050106 |